 |
FDA Approval Activities for this Drug
Celexa (citalopram Hbr), 10 mg/5 ml Solution, Forest NDA 21-046 12/22/99 1/3/00 8/8/02 Celexa (citalopram hydrobromide) Tablets & Solution, 10, 20 & 40 mg and 10mg/5 ml respectively, Forest NDA 20-822/S19 & 21-046/S3 11/19/02 11/22/02
Celexa (citalopram hydrobromide) Tablets, 20 mg/40 mg/60 mg Forest NDA 20-822 Celexa Indication: Depression
Celexa (citalopram hydrobromide) Tablets & Oral Solution, Forest Laboratories Celexa (citalopram hydrobromide) Oral Solution, Forest Laboratories
Celexa (citalopram hydrobromide) Tablets, Forest Laboratories | Citalopram Hydrobromide Tablets, Eon Labs, Approval
| Citalopram Hydrobromide Tablets, Dr. Reddy’s Labs, Approval
| Citalopram Hydrobromide Tablets, CorePharma, Approval
| Citalopram Hydrobromide Tablets, Aurobindo Pharma, Approval
| Citalopram Hydrobromide Tablets, Purepac Pharma, Approval | Citalopram Hydrobromide Tablets, Alphapharm, Approval
| Citalopram Hydrobromide Tablets, Kali Labs, Approval
| Citalopram Hydrobromide Tablets, Watson Labs, Approval | Citalopram Hydrobromide Tablets, Caraco Pharma, Approval | Citalopram Hydrobromide Tablets, Ivax Pharma, Approval | Citalopram Hydrobromide Oral Solution, Roxane Lab, Approval | Citalopram Hydrobromide Tablets, Mylan Pharma, Approval | Celexa (citalopram hydrobromide) Tablets, Forest Labs, Labeling Revision
| Celexa (citalopram hydrobromide) Oral Solution, Forest Labs, Labeling Revision | Citalopram Hydrobromide Tablets, Akyma Pharma, Approval
For the most up-to-date approval information, please locate this API using the drug index.
|